Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (371-380 of 481) with videos related to

Pageof 49
Sort By:
The Oncologist|October 10, 2019
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced CancerMargaret E Gatti-Mays, Jason M Redman, Renee N Donahue, et al.
Blood|February 21, 2019
Viral, immunologic, and clinical features of primary effusion lymphomaKathryn Lurain, Mark N Polizzotto, Karen Aleman, et al.
Surgery|December 5, 2009
Reoperation for parathyroid adenoma: a contemporary experienceAnathea C Powell, H Richard Alexander, Richard Chang, et al.
Cancer Medicine|January 11, 2024
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinomaCecilia Monge, Changqing Xie, Yuta Myojin, et al.
JAMA Oncology|August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical TrialChristopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2014
A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational studyAnish Thomas, Arun Rajan, Eva Szabo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part SarcomaJames Nguyen, Naoko Takebe, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2011
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapySteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitorAntoinette R Tan, Xiaowei Yang, Stephen M Hewitt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with VandetanibIra L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pageof 49

Showing results (371-380 of 481) with videos related to

Sort By:
Pageof 49
The Oncologist|October 10, 2019
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced CancerMargaret E Gatti-Mays, Jason M Redman, Renee N Donahue, et al.
Blood|February 21, 2019
Viral, immunologic, and clinical features of primary effusion lymphomaKathryn Lurain, Mark N Polizzotto, Karen Aleman, et al.
Surgery|December 5, 2009
Reoperation for parathyroid adenoma: a contemporary experienceAnathea C Powell, H Richard Alexander, Richard Chang, et al.
Cancer Medicine|January 11, 2024
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinomaCecilia Monge, Changqing Xie, Yuta Myojin, et al.
JAMA Oncology|August 21, 2015
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical TrialChristopher R Heery, Nuhad K Ibrahim, Philip M Arlen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2014
A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational studyAnish Thomas, Arun Rajan, Eva Szabo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part SarcomaJames Nguyen, Naoko Takebe, Shivaani Kummar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2011
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapySteven A Rosenberg, James C Yang, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitorAntoinette R Tan, Xiaowei Yang, Stephen M Hewitt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2017
Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with VandetanibIra L Kraft, Srivandana Akshintala, Yuelin Zhu, et al.
Pageof 49